Drawing for VALIGEN

USPTO serial 76081290

VALIGEN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
ROTH, JASON I
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VALIGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

S. Leslie Misrock

S LESLIE MISROCK PENNIE & EDMONDS LLP1155 AVE OF THE AMERICASNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001OLIGONUCLEOTIDES FOR INTRODUCING SITE SPECIFIC MUTATIONS IN A CELLACTIVE
005PHARMACEUTICAL PREPARATIONS CONTAINING A CARRIER FOR THE IN VIVO DELIVERY TO HEPATOCYTES OF OLIGONUCLEOTIDES THAT CAN ALTER A GENE OF THE HEPATOCYTE FOR THE PURPOSE OF TREATING GENETIC DEFECTS, METABOLIC DISORDERS, INFECTIOUS DISEASES AND NEOPLASTIC DISEASESACTIVE
010GENETICALLY MODIFIED ANIMAL ORGANS FOR IMPLANTATION INTO HUMANSACTIVE
031GENETICALLY MODIFIED LIVING PLANTS, LIVE RODENTS, AND VIABLE PLANT SEEDSACTIVE
035COMPUTERIZED GENOME DATABASE MANAGEMENT FOR DRUG DISCOVERYACTIVE
040MANUFACTURE OF GENETICALLY MODIFIED RODENTS, PLANTS AND SEEDS MADE TO THE ORDER AND SPECIFICATION OF OTHERS; MANUFACTURE OF GENETICALLY MODIFIED ANIMAL ORGANS FOR IMPLANTATION INTO HUMANS MADE TO THE ORDER AND SPECIFICATION OF OTHERS, MANUFACTURE OF OLIGONUCLEOTIDES FOR INTRODUCING SITE SPECIFIC MUTATIONS IN A CELL MADE TO THE ORDER AND SPECIFICATION OF OTHERSACTIVE
042DEVELOPMENT OF GENETIC INTERVENTION PRODUCTS FOR APPLICATIONS SUCH AS DRUG DISCOVERY, DIAGNOSTICS, AGRONOMIC BIOLOGICAL ENGINEERING, GENOMIC RESEARCH, NAMELY, DEVELOPING, COMPILING AND SUPPLYING TO OTHERS SPECIALTY IDENTIFICATION OF GENES, POPULATION-BASED IDENTIFICATION OF DISEASE-ASSOCIATED GENES, GENE MUTATION SCREENING AND DEVELOPMENT OF DATABASESACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 14, 2002ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 31, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 8, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 25, 2001NPUBNOTICE OF PUBLICATION
Jan 12, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 2000CNEAEXAMINER'S AMENDMENT MAILED
Nov 30, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2000DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance